Table 2 Comparison of sociodemographic data and comorbidities between COVID-19 patients with and without CMV or EBV coinfection (n = 110)
From: Epstein–Barr virus and cytomegalovirus coinfection in Egyptian COVID-19 patients
Either CMV or EBV | P | ||||
|---|---|---|---|---|---|
Negative (n = 100) | Positive (n = 10) | ||||
N | % | N | % | ||
Age | |||||
Less than or equal 60 years | 60 | 60.0% | 6 | 60.0% | 1.000 |
More than 60 years | 40 | 40.0% | 4 | 40.0% | |
Gender | |||||
Male | 50 | 50.0% | 6 | 60.0% | .742 |
Female | 50 | 50.0% | 4 | 40.0% | |
Special habits | |||||
No special habits | 95 | 95.0% | 9 | 90.0% | .151 |
Smoking | 5 | 5.0% | 0 | 0.0% | |
Smoking, alcoholic, and addiction | 0 | 0.0% | 1 | 10.0% | |
No comorbidities | |||||
No | 54 | 54.0% | 7 | 70.0% | .507 |
Yes | 46 | 46.0% | 3 | 30.0% | |
DM | |||||
No | 62 | 62.0% | 5 | 50.0% | .509 |
Yes | 38 | 38.0% | 5 | 50.0% | |
HTN | |||||
No | 64 | 64.0% | 5 | 50.0% | .496 |
Yes | 36 | 36.0% | 5 | 50.0% | |
IHD | |||||
No | 92 | 92.0% | 9 | 90.0% | .590 |
Yes | 8 | 8.0% | 1 | 10.0% | |
BA and COPD | |||||
No | 96 | 96.0% | 10 | 100.0% | 1.000 |
Yes | 4 | 4.0% | 0 | 0.0% | |
Cardiomyopathy and HF | |||||
No | 98 | 98.0% | 9 | 90.0% | .251 |
Yes | 2 | 2.0% | 1 | 10.0% | |
kidney disease | |||||
No | 99 | 99.0% | 8 | 80.0% | .021* |
Yes | 1 | 1.0% | 2 | 20.0% | |
Others | |||||
No | 97 | 97.0% | 9 | 90.0% | .321 |
Yes | 3 | 3.0% | 1 | 10.0% | |
No comorbidities | |||||
No | 54 | 54.0% | 7 | 70.0% | .507 |
Yes | 3 | 3.0% | 1 | 10.0% | |